Patents/Assignees

Eli Lilly And Company

215 patents in portfolio

US12453755utility2025
GIP/GLP1 Agonist Compositions
0 cites
US12453756utility2025
GIP/GLP1 Agonist Compositions
0 cites
US12453758utility2025
Method of Using a GIP/GLP1 Co-agonist for Diabetes
0 cites
US12453771utility2025
Methods of Treating Cancer Using Anti-cd137 Antibodies
0 cites
US12454511utility2025
6-methoxy-3,4-dihydro-1h-isoquinolin Compounds
0 cites
US12454512utility2025
Processes and Intermediates for the Preparation of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethenone
0 cites
US12440493utility2025
Combination Therapy for Treating Cancer Comprising Substituted Piperazines
0 cites
US12441714utility2025
Pyrrolidine Compounds
0 cites
USD1096390design2025
Box
0 cites
US12435084utility2025
Indazole Derivatives as Inhibitors of SARM1
0 cites
USD1095606design2025
Display Screen with a Graphical User Interface
0 cites
US12427245utility2025
Medication Delivery Device with Dose Detection System
0 cites
US12428377utility2025
Sodium-hydrogen Exchanger 3 Inhibitor Compounds
0 cites
US12420018utility2025
Devices and Processes for Delivery of Therapeutic Fluids
0 cites
USD1092726design2025
Portion of a Drug Delivery Device
0 cites
US12410227utility2025
Incretin Analogs and Uses Thereof
0 cites
US12404298utility2025
Glucocorticoid Receptor Agonists
0 cites
US12397119utility2025
Medication Delivery Device with Sensing System
0 cites
US12383681utility2025
Medication Delivery Device Including Disposable and Reusable Portions
0 cites
US12371465utility2025
Incretin Analogs and Uses Thereof
0 cites

← PreviousPage 3 of 11Next →